Joint Response to the HERC IP Framework Consultation

Posted: 20 October 2021

Research Australia, Medicines Australia, the Medical Technology Association of Australia (MTAA) and AusBiotech have responded to the HERC IP Framework Consultation paper.

Together, they represent a significant proportion of the health R&D sector and consider it positive that the Department has identified barriers to negotiating and executing commercialisation agreements between universities and business.

However, while they believe the development of a standard IP Framework could be of great assistance to all parties in reaching agreement on commercialisation arrangements, this is an incredibly complex area that requires careful and in-depth consultation.

Apart from the need to conduct an in-depth consultation, the major issue of concern with the Framework relates to the proposal to make use of the IP Framework mandatory in many circumstances.

Click here to read the full response document


News & opinion

Member Directory